Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,099,872
+$735,662 QoQ
Shares Held
87,204
+79.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#936
of 2,816 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALERUS FINANCIAL NA holds $65,318,341 across 13 Drug Manufacturers - General names. PFE ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,766 | $20,109,645 | |
| 2 | JNJ |
Johnson & Johnson
|
74,659 | $18,961,146 | |
| 3 | ABBV |
AbbVie Inc.
|
48,063 | $12,094,573 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,144 | $8,242,504 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,984 | $2,476,738 | |
| 6 | PFE |
Pfizer Inc
This page
|
87,204 | $2,099,872 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,022 | $1,139,839 | |
| 8 | AZN |
Astrazeneca PLC
|
586 | $111,117 |
All Filings in PFE
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,099,872 | 87,204 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,364,210 | 48,583 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $43,077 | 1,730 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $44,080 | 1,730 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $70,853 | 2,923 | Shares | Sole | 2025-08-13 | |
| 2023-09-30 | $263,203 | 7,935 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $301,803 | 8,228 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $641,906 | 15,733 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,137,783 | 139,301 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,128,220 | 25,782 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,032,543 | 115,059 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,808,852 | 112,205 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $5,927,025 | 100,373 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,194,059 | 120,764 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,988,005 | 127,375 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $5,008,942 | 138,254 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $5,104,700 | 138,677 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $6,171,722 | 168,167 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,581,045 | 140,093 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $4,887,311 | 149,734 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||